ASHLEY HOOVER: Open Payments
NPI 1154665883 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,451 in 67 payments from 14 companies in 2025. Trend: 2023 $541 · 2024 $966 · 2025 $1,451
Food & beverage: $1,451
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 19 | $328 |
| ABBVIE INC. | 8 | $233 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $180 |
| Neurocrine BioSciences, Inc. | 3 | $179 |
| Vanda Pharmaceuticals Inc. | 5 | $97 |
| Lundbeck LLC | 5 | $97 |
| Alkermes, Inc. | 3 | $77 |
| Otsuka America Pharmaceutical, Inc. | 3 | $61 |
| Collegium Pharmaceutical, Inc. | 3 | $57 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $56 |
Products named: Auvelity, VRAYLAR, CAPLYTA, INGREZZA, REXULTI, ARISTADA, Jornay PM, HETLIOZ.
Industry payments across VA — which companies pay providers there.
